Latest from the Blog

1. January 14, 2021

   NBTS Brain Tumor Clinical Trials Report: Q4 2020

   It can be hard to keep track of new clinical trial opportunities opening across the United States, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for […]

   Read more | 
2. January 7, 2021

   New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

   Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

   Read more | 
3. December 19, 2020

   4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology

   A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]

   Read more |